# Midodrine Use in Septic Shock

> **NCT03706053** · PHASE3 · TERMINATED · sponsor: **University of Virginia** · enrollment: 10 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Midodrine Hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03706053
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-05
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-02-11
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** No funding for the study; not enough staff
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03706053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03706053, "Midodrine Use in Septic Shock". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03706053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*